Dr. Thomas M. File JR., MD
Infectious Disease (Infectious Disease Physician)
At a glance
- In the NPI registry since
- 2006
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
OH license 35038143
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tivicay (dolutegravir sodium) | 21 |
| Biktarvy (bictegrav/emtricit/tenofov ala) | 17 |
| Descovy (emtricitabine/tenofov alafenam) | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 24 payments worth $31,562 in total to this clinician.
| Merck Sharp & Dohme LLC | $17,256 |
|---|---|
| Shionogi Inc | $8,770 |
| Pfizer Inc. | $3,621 |
| Paratek Pharmaceuticals, Inc. | $1,915 |
| Travel and Lodging | $12,223 |
|---|---|
| Consulting Fee | $11,709 |
| Compensation for services other than consulting (speaking, faculty) | $7,111 |
| Food and Beverage | $520 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Sep 16, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $9,526 |
| Merck Sharp & Dohme LLC Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionPayment made to Third Party Organization not to Physician. | $6,540 |
| Shionogi Inc Aug 21, 2025 | Consulting Fee Fetroja · Infections and Infectious Diseases | $4,194 |
| Pfizer Inc. Oct 30, 2025 | Consulting Fee PREVNAR 20 · VACCINES | $3,050 |
| Shionogi Inc Mar 20, 2025 | Consulting Fee S-217622 · Infections and Infectious Diseases | $2,575 |
| Shionogi Inc Mar 20, 2025 | Consulting Fee Fetroja · Infections and Infectious Diseases | $1,890 |
| Paratek Pharmaceuticals, Inc. Jun 18, 2025 | Travel and Lodging NUZYRA · ANTIBIOTIC · travel to SAN FRANCISCO, CA | $1,779 |
| Pfizer Inc. Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) PREVNAR 20 · VACCINES | $571 |
| Merck Sharp & Dohme LLC Sep 17, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $255 |
| Merck Sharp & Dohme LLC Sep 18, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $255 |
All 14 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Pfizer Inc. Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty) PREVNAR 20 · VACCINES | $571 |
| Pfizer Inc. Oct 30, 2025 | Consulting Fee PREVNAR 20 · VACCINES | $3,050 |
| Merck Sharp & Dohme LLC Oct 1, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionPayment made to Third Party Organization not to Physician. | $6,540 |
| Merck Sharp & Dohme LLC Oct 1, 2025 | Travel and Lodging travel to Madrid, Spain | $59.65 |
| Merck Sharp & Dohme LLC Sep 19, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $153 |
| Merck Sharp & Dohme LLC Sep 18, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $255 |
| Merck Sharp & Dohme LLC Sep 17, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $255 |
| Merck Sharp & Dohme LLC Sep 17, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $153 |
| Merck Sharp & Dohme LLC Sep 17, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $42.22 |
| Merck Sharp & Dohme LLC Sep 16, 2025 | Travel and Lodging CAPVAXIVE · VACCINE · travel to Madrid, Spain · in-kind | $9,526 |
| Shionogi Inc Aug 21, 2025 | Consulting Fee Fetroja · Infections and Infectious Diseases | $4,194 |
| Paratek Pharmaceuticals, Inc. Jun 18, 2025 | Travel and Lodging NUZYRA · ANTIBIOTIC · travel to SAN FRANCISCO, CA | $1,779 |
| Shionogi Inc Mar 20, 2025 | Consulting Fee S-217622 · Infections and Infectious Diseases | $2,575 |
| Shionogi Inc Mar 20, 2025 | Consulting Fee Fetroja · Infections and Infectious Diseases | $1,890 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.